Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Multiple biomarkers for risk prediction in chronic heart failure.

Ky B, French B, Levy WC, Sweitzer NK, Fang JC, Wu AH, Goldberg LR, Jessup M, Cappola TP.

Circ Heart Fail. 2012 Mar 1;5(2):183-90. doi: 10.1161/CIRCHEARTFAILURE.111.965020. Epub 2012 Feb 23.

2.

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.

Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, Dries DL, Tang WH, Wu AH, Fang JC, Boxer R, Sweitzer NK, Levy WC, Goldberg LR, Jessup M, Cappola TP.

Circ Heart Fail. 2011 Mar;4(2):180-7. doi: 10.1161/CIRCHEARTFAILURE.110.958223. Epub 2010 Dec 22.

3.

Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.

Bayes-Genis A, de Antonio M, Vila J, Peñafiel J, Galán A, Barallat J, Zamora E, Urrutia A, Lupón J.

J Am Coll Cardiol. 2014 Jan 21;63(2):158-66. doi: 10.1016/j.jacc.2013.07.087. Epub 2013 Sep 24.

4.
5.

Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.

May HT, Horne BD, Levy WC, Kfoury AG, Rasmusson KD, Linker DT, Mozaffarian D, Anderson JL, Renlund DG.

Am J Cardiol. 2007 Aug 15;100(4):697-700. Epub 2007 Jun 26.

PMID:
17697831
6.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

PMID:
19539088
7.

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL.

Circulation. 2012 Sep 25;126(13):1596-604. Epub 2012 Aug 20.

8.

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

Tziakas DN, Chalikias GK, Stakos D, Chatzikyriakou SV, Papazoglou D, Mitrousi K, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Eur J Prev Cardiol. 2012 Feb;19(1):62-71. doi: 10.1097/HJR.0b013e32833ace76. Epub 2011 Jan 28.

PMID:
20479644
9.

Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.

de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.

Am Heart J. 2012 May;163(5):821-8. doi: 10.1016/j.ahj.2012.03.004.

PMID:
22607860
10.

Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.

Cabassi A, de Champlain J, Maggiore U, Parenti E, Coghi P, Vicini V, Tedeschi S, Cremaschi E, Binno S, Rocco R, Bonali S, Bianconcini M, Guerra C, Folesani G, Montanari A, Regolisti G, Fiaccadori E.

Int J Cardiol. 2013 Oct 9;168(4):3334-9. doi: 10.1016/j.ijcard.2013.04.039. Epub 2013 Apr 25.

PMID:
23623341
11.

The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Ky B, French B, Ruparel K, Sweitzer NK, Fang JC, Levy WC, Sawyer DB, Cappola TP.

J Am Coll Cardiol. 2011 Jul 19;58(4):386-94. doi: 10.1016/j.jacc.2011.03.032.

12.

Diagnostic and prognostic value of uric acid in patients with acute dyspnea.

Reichlin T, Potocki M, Breidthardt T, Noveanu M, Hartwiger S, Burri E, Klima T, Stelzig C, Laule K, Mebazaa A, Christ M, Mueller C.

Am J Med. 2009 Nov;122(11):1054.e7-1054.e14. doi: 10.1016/j.amjmed.2009.04.023.

PMID:
19854335
13.

Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure.

Arenja N, Reichlin T, Drexler B, Oshima S, Denhaerynck K, Haaf P, Potocki M, Breidthardt T, Noveanu M, Stelzig C, Heinisch C, Twerenbold R, Reiter M, Socrates T, Mueller C.

J Intern Med. 2012 Jun;271(6):598-607. doi: 10.1111/j.1365-2796.2011.02469.x. Epub 2011 Nov 11.

14.
15.

Prognostic value of biomarkers in heart failure: application of novel methods in the community.

Dunlay SM, Gerber Y, Weston SA, Killian JM, Redfield MM, Roger VL.

Circ Heart Fail. 2009 Sep;2(5):393-400. doi: 10.1161/CIRCHEARTFAILURE.109.849299. Epub 2009 Jul 29.

16.

Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.

Miller WL, Grill DE, Struck J, Jaffe AS.

Am J Cardiol. 2013 Mar 15;111(6):880-5. doi: 10.1016/j.amjcard.2012.11.053. Epub 2012 Dec 28.

PMID:
23276468
17.

Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.

Balling L, Kistorp C, Schou M, Egstrup M, Gustafsson I, Goetze JP, Hildebrandt P, Gustafsson F.

J Card Fail. 2012 May;18(5):351-8. doi: 10.1016/j.cardfail.2012.01.019. Epub 2012 Mar 10.

PMID:
22555263
18.

ST2 pathogenetic profile in ambulatory heart failure patients.

Bayes-Genis A, Januzzi JL, Gaggin HK, de Antonio M, Motiwala SR, Zamora E, Galán A, Domingo M, Urrutia A, Lupón J.

J Card Fail. 2015 Apr;21(4):355-61. doi: 10.1016/j.cardfail.2014.10.014. Epub 2014 Nov 3.

PMID:
25451702
19.

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.

Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, Kuskowski M, Cohn JN, Drexler H, Wollert KC.

Circulation. 2010 Oct 5;122(14):1387-95. doi: 10.1161/CIRCULATIONAHA.109.928846. Epub 2010 Sep 20.

20.

Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.

Tang WH, Shrestha K, Troughton RW, Borowski AG, Klein AL.

Congest Heart Fail. 2011 May-Jun;17(3):105-9. doi: 10.1111/j.1751-7133.2011.00221.x. Epub 2011 Mar 31.

Supplemental Content

Support Center